MAPT and Alzheimer disease: Improved AD models in C. elegans are obtained by crossing Aβ1‐42 (line CL2355) with a transgenic strain expressing pan‐neuronal tau, either pro‐ (line BR5270) or anti‐aggregating tau (line BR5271).173